CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Aug. 31, 2012	Nov. 30, 2011
ASSETS
Cash and cash equivalents	$ 304,169	$ 405,327
Grant receivable	0	303,102
Other current assets	10,293	10,598
Total current assets	314,462	719,027
Property and equipment, net of accumulated depreciation of $66,467	0	0
Other assets	1,685	1,685
Total assets	316,147	720,712
LIABILITIES AND EQUITY (DEFICIENCY)
Accounts payable and accrued expenses	1,333,286	1,304,422
Payable to related party	50,000	50,000
Advance from debenture holder	0	301,930
Current portion of deferred revenue	49,318	49,318
Total current liabilities	1,432,604	1,705,670
Non-current liabilities
Convertible debentures, net of discount	57,306	59,596
Deferred revenue, net of current portion	511,071	548,059
Derivative liability related to Series B convertible preferred stock	56,460	160,986
Total non-current liabilities	624,837	768,641
Total liabilities	2,057,441	2,474,311
Commitments and contingencies
Equity (Deficiency)
Preferred Stock	0	0
Common stock, $0.01 par value; 3,000,000,000 shares authorized; 1,148,051,557 and 823,385,986 shares issued and outstanding at August 31, 2012 and November 30, 2011, respectively	11,480,516	8,233,860
Additional paid-in capital	27,846,025	30,064,619
Accumulated deficit	(41,942,260)	(40,998,344)
Total MultiCell Technologies, Inc. stockholders' equity (deficiency)	(692,475)	(776,621)
Noncontrolling interests	(1,048,819)	(976,978)
Total equity (deficiency)	(1,741,294)	(1,753,599)
Total liabilities and equity (deficiency)	316,147	720,712
Series B Convertible Preferred Stock [Member]
Equity (Deficiency)
Preferred Stock	1,349,844	1,349,844
Total equity (deficiency)	1,349,844	1,349,844
Series I Convertible Preferred Stock [Member]
Equity (Deficiency)
Preferred Stock	573,400	573,400
Total equity (deficiency)	$ 573,400	$ 573,400